Breaking News

Today
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Conference/Events
Denny's participates in a conference call with MKM Partners » 12:57
11/25/20
11/25
12:57
11/25/20
12:57
DENN

Denny's

$11.48 /

-0.26 (-2.21%)

Conference call with…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
DENN Denny's
$11.48 /

-0.26 (-2.21%)

DENN Denny's
$11.48 /

-0.26 (-2.21%)

11/13/20 Wedbush
Denny's price target raised to $13.50 from $13 at Wedbush
08/27/20 Stephens
Denny's catalyst will be easing of COVID restrictions, says Stephens
07/13/20
Fly Intel: Top five analyst downgrades
07/13/20 Stephens
Denny's downgraded to Equal Weight from Overweight at Stephens
DENN Denny's
$11.48 /

-0.26 (-2.21%)

  • 01
    Jul
DENN Denny's
$11.48 /

-0.26 (-2.21%)

DENN Denny's
$11.48 /

-0.26 (-2.21%)

DENN Denny's
$11.48 /

-0.26 (-2.21%)

Yesterday
Periodicals
Citron puts $700 target on MicroStrategy, says best way to play bitcoin » 12:01
11/24/20
11/24
12:01
11/24/20
12:01
MSTR

MicroStrategy

$238.28 /

+17.53 (+7.94%)

Andrew Left's Citron…

Andrew Left's Citron Research says MicroStrategy (MSTR) is the best way to own bitcoin in the stock market. The firm, in a new report posted on its website, put a $700 price target on MicroStrategy shares. The stock in midday trading is up 9%, or $18.93, to $239.69. "Today, we are long bitcoin as we believe there is no better inflation hedge in the market," Citron wrote. The business intelligence company owns more bitcoin than any other publicly traded company, Citron points out. In Q3, MicroStrategy invested $425M to purchase 38,250 bitcoins, which have a current market value of over $700M. Therefore, MicroStrategy is trading at just 2.5 times sales, according to Citron. If bitcoin trades to $50,000, MicroStrategy could be worth $700 per share, it claims. Reference Link

ShowHide Related Items >><<
MSTR MicroStrategy
$238.28 /

+17.53 (+7.94%)

MSTR MicroStrategy
$238.28 /

+17.53 (+7.94%)

11/17/20 BWS Financial
MicroStrategy price target raised to $230 from $200 at BWS Financial
MSTR MicroStrategy
$238.28 /

+17.53 (+7.94%)

MSTR MicroStrategy
$238.28 /

+17.53 (+7.94%)

MSTR MicroStrategy
$238.28 /

+17.53 (+7.94%)

Periodicals
Citron puts $700 price target MicroStrategy shares  11:55
11/24/20
11/24
11:55
11/24/20
11:55
MSTR

MicroStrategy

$238.33 /

+17.58 (+7.96%)

 
ShowHide Related Items >><<
MSTR MicroStrategy
$238.33 /

+17.58 (+7.96%)

MSTR MicroStrategy
$238.33 /

+17.58 (+7.96%)

11/17/20 BWS Financial
MicroStrategy price target raised to $230 from $200 at BWS Financial
MSTR MicroStrategy
$238.33 /

+17.58 (+7.96%)

MSTR MicroStrategy
$238.33 /

+17.58 (+7.96%)

MSTR MicroStrategy
$238.33 /

+17.58 (+7.96%)

Periodicals
MicroStrategy best way to own bitcoin in stock market, Citron says  11:55
11/24/20
11/24
11:55
11/24/20
11:55
MSTR

MicroStrategy

$238.33 /

+17.58 (+7.96%)

, BTC

Bitcoin

$0.00 /

+ (+0.00%)

 
ShowHide Related Items >><<
MSTR MicroStrategy
$238.33 /

+17.58 (+7.96%)

BTC Bitcoin
$0.00 /

+ (+0.00%)

MSTR MicroStrategy
$238.33 /

+17.58 (+7.96%)

11/17/20 BWS Financial
MicroStrategy price target raised to $230 from $200 at BWS Financial
BTC Bitcoin
$0.00 /

+ (+0.00%)

01/23/20 Morgan Stanley
PayPal acceptance gap widens against Amazon, Bitcoin, says Morgan Stanley
MSTR MicroStrategy
$238.33 /

+17.58 (+7.96%)

BTC Bitcoin
$0.00 /

+ (+0.00%)

BTC Bitcoin
$0.00 /

+ (+0.00%)

MSTR MicroStrategy
$238.33 /

+17.58 (+7.96%)

BTC Bitcoin
$0.00 /

+ (+0.00%)

Upgrade
Chubb upgraded to Strong Buy from Outperform at Raymond James » 08:45
11/24/20
11/24
08:45
11/24/20
08:45
CB

Chubb

$149.17 /

+0.26 (+0.17%)

Raymond James analyst…

Raymond James analyst Gregory Peters upgraded Chubb to Strong Buy from Outperform with a price target of $180, up from $150, following the strongest commercial pricing environment in at least 15 years. On a consolidated basis, Peters says Chubb is experiencing rate increase in more than 50% of its business with tightening policy terms/conditions, important ingredients for a classic hard market, which should lead to an improving EPS picture.

ShowHide Related Items >><<
CB Chubb
$149.17 /

+0.26 (+0.17%)

CB Chubb
$149.17 /

+0.26 (+0.17%)

11/24/20 Raymond James
Chubb upgraded to Strong Buy from Outperform at Raymond James
11/17/20 Barclays
Chubb initiated with an Overweight at Barclays
11/10/20 Goldman Sachs
Chubb upgraded to Buy from Sell at Goldman Sachs
11/03/20 Credit Suisse
Chubb price target raised to $152 from $144 at Credit Suisse
CB Chubb
$149.17 /

+0.26 (+0.17%)

CB Chubb
$149.17 /

+0.26 (+0.17%)

CB Chubb
$149.17 /

+0.26 (+0.17%)

CB Chubb
$149.17 /

+0.26 (+0.17%)

Options
Largest borrow rate increases among liquid names » 08:45
11/24/20
11/24
08:45
11/24/20
08:45
ACI

Albertsons

$15.91 /

+0.195 (+1.24%)

, VUZI

Vuzix

$3.97 /

+0.07 (+1.79%)

, SBE

Switchback Energy Acquisition

$33.99 /

+7.845 (+30.01%)

, CODX

Co-Diagnostics

$10.50 /

-0.61 (-5.49%)

, TRVN

Trevena

$2.40 /

-0.085 (-3.42%)

, REV

Revlon

$10.15 /

+0.56 (+5.84%)

, DENN

Denny's

$11.42 /

+0.845 (+7.99%)

, ACWI

iShares MSCI ACWI Index Fund

$86.76 /

+0.38 (+0.44%)

, EOSE

Eos Energy Enterprises

$15.48 /

+1.48 (+10.57%)

, VLDR

Velodyne Lidar

$16.75 /

+0.38 (+2.32%)

Latest data shows the…

Latest data shows the largest indicative borrow rate increases among liquid option names include: Albertsons (ACI) 7.80% +3.36, Vuzix (VUZI) 26.37% +1.22, Switchback Energy Acquisition Corp (SBE) 6.08% +0.29, Co-Diagnostics (CODX) 36.17% +0.28, Trevena (TRVN) 10.58% +0.18, Revlon (REV) 92.87% +0.14, Denny's (DENN) 0.39% +0.14, iShares MSCI ACWI Index Fund (ACWI) 0.42% +0.11, (EOSE) 2.36% +0.11, and Velodyne Lidar (VLDR) 10.45% +0.08.

ShowHide Related Items >><<
VUZI Vuzix
$3.97 /

+0.07 (+1.79%)

VLDR Velodyne Lidar
$16.75 /

+0.38 (+2.32%)

TRVN Trevena
$2.40 /

-0.085 (-3.42%)

SBE Switchback Energy Acquisition
$33.99 /

+7.845 (+30.01%)

REV Revlon
$10.15 /

+0.56 (+5.84%)

EOSE Eos Energy Enterprises
$15.48 /

+1.48 (+10.57%)

DENN Denny's
$11.42 /

+0.845 (+7.99%)

CODX Co-Diagnostics
$10.50 /

-0.61 (-5.49%)

ACI Albertsons
$15.91 /

+0.195 (+1.24%)

ACI Albertsons
$15.91 /

+0.195 (+1.24%)

10/23/20 Evercore ISI
Kroger downgraded to In Line from Outperform at Evercore ISI
10/06/20
Fly Intel: Top five analyst initiations
10/06/20 Northcoast
Albertsons initiated with a Buy at Northcoast
09/25/20 Tigress Financial
Albertsons initiated with a Buy at Tigress Financial
VUZI Vuzix
$3.97 /

+0.07 (+1.79%)

09/04/20 Craig-Hallum
Vuzix price target raised to $8 from $6 at Craig-Hallum
05/11/20 Alliance Global Partners
Vuzix downgraded to Neutral from Buy at Alliance Global Partners
SBE Switchback Energy Acquisition
$33.99 /

+7.845 (+30.01%)

CODX Co-Diagnostics
$10.50 /

-0.61 (-5.49%)

11/17/20 Maxim
Co-Diagnostics price target lowered to $20 from $30 at Maxim
11/17/20 H.C. Wainwright
Co-Diagnostics price target lowered to $29 from $33 at H.C. Wainwright
05/20/20 Maxim
Co-Diagnostics upgraded to Buy from Hold at Maxim
05/20/20 Maxim
Co-Diagnostics upgraded to Buy from Hold at Maxim
TRVN Trevena
$2.40 /

-0.085 (-3.42%)

09/14/20 Guggenheim
Guggenheim starts Trevena at Buy ahead of launch of Olinvyk
09/14/20 Guggenheim
Trevena initiated with a Buy at Guggenheim
08/28/20
Fly Intel: Top five analyst initiations
08/27/20 Cantor Fitzgerald
Trevena initiated with an Overweight at Cantor Fitzgerald
REV Revlon
$10.15 /

+0.56 (+5.84%)

03/11/20 Jefferies
Estee Lauder, Coty, L'Oreal price targets lowered at Jefferies
DENN Denny's
$11.42 /

+0.845 (+7.99%)

11/13/20 Wedbush
Denny's price target raised to $13.50 from $13 at Wedbush
08/27/20 Stephens
Denny's catalyst will be easing of COVID restrictions, says Stephens
07/13/20
Fly Intel: Top five analyst downgrades
07/13/20 Stephens
Denny's downgraded to Equal Weight from Overweight at Stephens
ACWI iShares MSCI ACWI Index Fund
$86.76 /

+0.38 (+0.44%)

EOSE Eos Energy Enterprises
$15.48 /

+1.48 (+10.57%)

11/20/20
Fly Intel: Top five analyst initiations
11/20/20 B. Riley Securities
Eos Energy Enterprises initiated with a Buy at B. Riley Securities
10/29/20 Northland
B. Riley Principal Merger II initiated with an Outperform at Northland
VLDR Velodyne Lidar
$16.75 /

+0.38 (+2.32%)

11/23/20 Craig-Hallum
Craig-Hallum bullish on Velodyne Lidar, initiates with a Buy
11/23/20 Craig-Hallum
Velodyne Lidar initiated with a Buy at Craig-Hallum
10/14/20 Oppenheimer
Velodyne Lidar initiated with an Outperform at Oppenheimer
10/01/20 Baird
Velodyne Lidar initiated with an Outperform at Baird
VUZI Vuzix
$3.97 /

+0.07 (+1.79%)

REV Revlon
$10.15 /

+0.56 (+5.84%)

DENN Denny's
$11.42 /

+0.845 (+7.99%)

CODX Co-Diagnostics
$10.50 /

-0.61 (-5.49%)

ACI Albertsons
$15.91 /

+0.195 (+1.24%)

  • 12
    Aug
  • 01
    Jul
  • 26
    Jun
TRVN Trevena
$2.40 /

-0.085 (-3.42%)

SBE Switchback Energy Acquisition
$33.99 /

+7.845 (+30.01%)

REV Revlon
$10.15 /

+0.56 (+5.84%)

DENN Denny's
$11.42 /

+0.845 (+7.99%)

ACI Albertsons
$15.91 /

+0.195 (+1.24%)

VLDR Velodyne Lidar
$16.75 /

+0.38 (+2.32%)

TRVN Trevena
$2.40 /

-0.085 (-3.42%)

REV Revlon
$10.15 /

+0.56 (+5.84%)

DENN Denny's
$11.42 /

+0.845 (+7.99%)

CODX Co-Diagnostics
$10.50 /

-0.61 (-5.49%)

ACI Albertsons
$15.91 /

+0.195 (+1.24%)

VUZI Vuzix
$3.97 /

+0.07 (+1.79%)

VLDR Velodyne Lidar
$16.75 /

+0.38 (+2.32%)

TRVN Trevena
$2.40 /

-0.085 (-3.42%)

SBE Switchback Energy Acquisition
$33.99 /

+7.845 (+30.01%)

EOSE Eos Energy Enterprises
$15.48 /

+1.48 (+10.57%)

CODX Co-Diagnostics
$10.50 /

-0.61 (-5.49%)

ACI Albertsons
$15.91 /

+0.195 (+1.24%)

Initiation
2U initiated with an Equal Weight at Morgan Stanley » 08:06
11/24/20
11/24
08:06
11/24/20
08:06
TWOU

2U

$34.28 /

+0.17 (+0.50%)

Morgan Stanley analyst…

Morgan Stanley analyst Josh Baer initiated coverage of 2U with an Equal Weight rating and $39 price target. While 2U is a leader in Online Program Management and well positioned due to its exposure to the faster growing online portion of higher-education, Baer thinks its current business model likely limits its ability to profitably address the full market opportunity, he tells investors. Baer cites significant cash outlay when launching new graduate degrees limiting the number of new programs and enrollment growth and thinks partnering with higher-tier Universities means 2U cannot launch degree programs where it would be recruiting the same students for competing programs, the analyst explained.

ShowHide Related Items >><<
TWOU 2U
$34.28 /

+0.17 (+0.50%)

TWOU 2U
$34.28 /

+0.17 (+0.50%)

10/01/20 DA Davidson
2U price target lowered to $34 from $44 at DA Davidson
09/24/20 KeyBanc
Initial enrollment data from NSCRC 'positive' for Chegg, says KeyBanc
08/03/20 BMO Capital
2U price target raised to $54 from $48 at BMO Capital
07/31/20 Barrington
2U price target raised to $55 from $50 at Barrington
TWOU 2U
$34.28 /

+0.17 (+0.50%)

  • 06
    Aug
TWOU 2U
$34.28 /

+0.17 (+0.50%)

TWOU 2U
$34.28 /

+0.17 (+0.50%)

Upgrade
Chubb upgraded to Strong Buy from Outperform at Raymond James » 05:53
11/24/20
11/24
05:53
11/24/20
05:53
CB

Chubb

$149.17 /

+0.26 (+0.17%)

Raymond James analyst…

Raymond James analyst Gregory Peters upgraded Chubb to Strong Buy from Outperform with a price target of $180, up from $150.

ShowHide Related Items >><<
CB Chubb
$149.17 /

+0.26 (+0.17%)

CB Chubb
$149.17 /

+0.26 (+0.17%)

11/17/20 Barclays
Chubb initiated with an Overweight at Barclays
11/10/20 Goldman Sachs
Chubb upgraded to Buy from Sell at Goldman Sachs
11/03/20 Credit Suisse
Chubb price target raised to $152 from $144 at Credit Suisse
10/29/20 BofA
Chubb upgraded to Neutral at BofA with valuation gap to Travelers narrowed
CB Chubb
$149.17 /

+0.26 (+0.17%)

CB Chubb
$149.17 /

+0.26 (+0.17%)

CB Chubb
$149.17 /

+0.26 (+0.17%)

CB Chubb
$149.17 /

+0.26 (+0.17%)

Friday
On The Fly
Fly Intel: Wall Street's top stories for Friday » 16:22
11/20/20
11/20
16:22
11/20/20
16:22
PFE

Pfizer

$36.70 /

+0.51 (+1.41%)

, BNTX

BioNTech

$104.00 /

+9.17 (+9.67%)

, FL

Foot Locker

$39.30 /

-2.06 (-4.98%)

, WDAY

Workday

$209.38 /

-21.42 (-9.28%)

, FEYE

FireEye

$15.14 /

+0.91 (+6.39%)

, BA

Boeing

$199.62 /

-6.01 (-2.92%)

, MESO

Mesoblast

$13.88 /

+2.11 (+17.93%)

, NVS

Novartis

$87.51 /

+0.285 (+0.33%)

, WSM

Williams-Sonoma

$107.76 /

+6.52 (+6.44%)

, AVRO

Avrobio

$13.99 /

-2.96 (-17.46%)

, GSX

GSX Techedu

$65.66 /

-5.845 (-8.17%)

, POST

Post Holdings

$90.53 /

-6.07 (-6.28%)

The major averages slid…

ShowHide Related Items >><<
WSM Williams-Sonoma
$107.76 /

+6.52 (+6.44%)

WDAY Workday
$209.38 /

-21.42 (-9.28%)

POST Post Holdings
$90.53 /

-6.07 (-6.28%)

PFE Pfizer
$36.70 /

+0.51 (+1.41%)

NVS Novartis
$87.51 /

+0.285 (+0.33%)

MESO Mesoblast
$13.88 /

+2.11 (+17.93%)

GSX GSX Techedu
$65.66 /

-5.845 (-8.17%)

FL Foot Locker
$39.30 /

-2.06 (-4.98%)

FEYE FireEye
$15.14 /

+0.91 (+6.39%)

BNTX BioNTech
$104.00 /

+9.17 (+9.67%)

BA Boeing
$199.62 /

-6.01 (-2.92%)

AVRO Avrobio
$13.99 /

-2.96 (-17.46%)

PFE Pfizer
$36.70 /

+0.51 (+1.41%)

11/19/20
Fly Intel: Top five analyst initiations
11/19/20 Goldman Sachs
Pfizer reinstated with a Neutral at Goldman Sachs
11/17/20 Benchmark
Inovio on 'top-10 vaccine contenders list,' says Benchmark
11/17/20 Maxim
Co-Diagnostics price target lowered to $20 from $30 at Maxim
BNTX BioNTech
$104.00 /

+9.17 (+9.67%)

11/16/20 Piper Sandler
Piper boosts Moderna target to $166 after 'impressive' vaccine response
11/12/20 Canaccord
BioNTech price target raised to $115 from $112 at Canaccord
11/12/20 B. Riley Securities
Altimmune selloff on vaccine news overblown, says B. Riley Securities
FL Foot Locker
$39.30 /

-2.06 (-4.98%)

11/18/20 B. Riley Securities
Foot Locker price target raised to $36 from $30 at B. Riley Securities
11/18/20 Pivotal Research
Foot Locker price target raised to $46 from $39 at Pivotal Research
11/17/20 Wedbush
Foot Locker price target raised to $44 from $37 at Wedbush
11/16/20 Raymond James
Foot Locker price target raised to $50 from $35 at Raymond James
WDAY Workday
$209.38 /

-21.42 (-9.28%)

11/20/20 Loop Capital
Workday price target raised to $180 from $170 at Loop Capital
11/20/20 Canaccord
Workday weakness following earnings should be bought, says Canaccord
11/20/20 BMO Capital
Workday price target lowered to $260 from $265 at BMO Capital
11/20/20 Credit Suisse
Workday price target raised to $230 from $215 at Credit Suisse
FEYE FireEye
$15.14 /

+0.91 (+6.39%)

11/20/20 Barclays
FireEye downgraded to Underweight on long transformation at Barclays
11/20/20 Barclays
FireEye downgraded to Underweight from Equal Weight at Barclays
10/14/20 Baird
FireEye added as positive Fresh Pick ahead of earnings at Baird
07/29/20 JPMorgan
FireEye price target raised to $18 from $15 at JPMorgan
BA Boeing
$199.62 /

-6.01 (-2.92%)

11/19/20 Susquehanna
Boeing price target raised to $275 from $220 at Susquehanna
11/18/20 Goldman Sachs
Boeing price target raised to $245 from $231 at Goldman Sachs
11/18/20 William Blair
Boeing 737 Max approval 'a modest positive' for ViaSat, says William Blair
11/18/20
Fly Intel: Top five analyst upgrades
MESO Mesoblast
$13.88 /

+2.11 (+17.93%)

10/22/20
Fly Intel: Top five analyst initiations
10/22/20 RBC Capital
Mesoblast initiated with a Sector Perform at RBC Capital
10/05/20 Maxim
Mesoblast price target lowered to $18 from $22 at Maxim
10/02/20 H.C. Wainwright
H.C. Wainwright cuts Mesoblast target after unexpected complete response letter
NVS Novartis
$87.51 /

+0.285 (+0.33%)

11/10/20 JPMorgan
Novartis price target raised to CHF 85 from CHF 82 at JPMorgan
10/26/20 JMP Securities
Kura Oncology price target raised to $33 from $22 at JMP Securities
09/29/20 Berenberg
Novartis initiated with a Buy at Berenberg
09/24/20 Barclays
Regenxbio price target lowered to $79 from $88 at Barclays
WSM Williams-Sonoma
$107.76 /

+6.52 (+6.44%)

11/20/20 RBC Capital
Williams-Sonoma price target raised to $117 from $101 at RBC Capital
11/20/20 Loop Capital
Williams-Sonoma price target raised to $110 from $100 at Loop Capital
11/20/20 Wedbush
Williams-Sonoma price target raised to $130 from $115 at Wedbush
11/20/20 Barclays
Williams-Sonoma price target raised to $144 from $112 at Barclays
AVRO Avrobio
$13.99 /

-2.96 (-17.46%)

11/18/20 Mizuho
Avrobio price target raised to $43 from $35 at Mizuho
11/11/20 Berenberg
Biotechnology companies initiated at Berenberg
11/11/20 Berenberg
Avrobio initiated with a Buy at Berenberg
03/31/20 H.C. Wainwright
Avrobio downgraded to Neutral from Buy at H.C. Wainwright
GSX GSX Techedu
$65.66 /

-5.845 (-8.17%)

10/26/20 Barclays
GSX Techedu price target lowered to $66 from $77 at Barclays
10/22/20
Fly Intel: Top five analyst downgrades
10/22/20 Nomura
Nomura downgrades GSX Techedu to Reduce, cuts target to 'Street-low' $38
10/22/20 Nomura
GSX Techedu downgraded to Reduce from Neutral at Nomura
POST Post Holdings
$90.53 /

-6.07 (-6.28%)

06/22/20 Goldman Sachs
Post Holdings upgraded to Buy from Neutral at Goldman Sachs
05/04/20 Wells Fargo
Post Holdings price target lowered to $110 from $120 at Wells Fargo
04/09/20
Fly Intel: Top five analyst initiations
04/09/20 Citi
Post Holdings assumed with a Buy at Citi
WSM Williams-Sonoma
$107.76 /

+6.52 (+6.44%)

WDAY Workday
$209.38 /

-21.42 (-9.28%)

POST Post Holdings
$90.53 /

-6.07 (-6.28%)

PFE Pfizer
$36.70 /

+0.51 (+1.41%)

NVS Novartis
$87.51 /

+0.285 (+0.33%)

MESO Mesoblast
$13.88 /

+2.11 (+17.93%)

GSX GSX Techedu
$65.66 /

-5.845 (-8.17%)

FL Foot Locker
$39.30 /

-2.06 (-4.98%)

FEYE FireEye
$15.14 /

+0.91 (+6.39%)

BNTX BioNTech
$104.00 /

+9.17 (+9.67%)

BA Boeing
$199.62 /

-6.01 (-2.92%)

AVRO Avrobio
$13.99 /

-2.96 (-17.46%)

  • 20
    Nov
  • 23
    Jul
  • 13
    Feb
  • 06
    Feb
  • 21
    Nov
WSM Williams-Sonoma
$107.76 /

+6.52 (+6.44%)

POST Post Holdings
$90.53 /

-6.07 (-6.28%)

PFE Pfizer
$36.70 /

+0.51 (+1.41%)

NVS Novartis
$87.51 /

+0.285 (+0.33%)

GSX GSX Techedu
$65.66 /

-5.845 (-8.17%)

FEYE FireEye
$15.14 /

+0.91 (+6.39%)

BNTX BioNTech
$104.00 /

+9.17 (+9.67%)

BA Boeing
$199.62 /

-6.01 (-2.92%)

WSM Williams-Sonoma
$107.76 /

+6.52 (+6.44%)

WDAY Workday
$209.38 /

-21.42 (-9.28%)

PFE Pfizer
$36.70 /

+0.51 (+1.41%)

NVS Novartis
$87.51 /

+0.285 (+0.33%)

MESO Mesoblast
$13.88 /

+2.11 (+17.93%)

GSX GSX Techedu
$65.66 /

-5.845 (-8.17%)

FL Foot Locker
$39.30 /

-2.06 (-4.98%)

FEYE FireEye
$15.14 /

+0.91 (+6.39%)

BA Boeing
$199.62 /

-6.01 (-2.92%)

AVRO Avrobio
$13.99 /

-2.96 (-17.46%)

WSM Williams-Sonoma
$107.76 /

+6.52 (+6.44%)

WDAY Workday
$209.38 /

-21.42 (-9.28%)

PFE Pfizer
$36.70 /

+0.51 (+1.41%)

MESO Mesoblast
$13.88 /

+2.11 (+17.93%)

GSX GSX Techedu
$65.66 /

-5.845 (-8.17%)

FL Foot Locker
$39.30 /

-2.06 (-4.98%)

FEYE FireEye
$15.14 /

+0.91 (+6.39%)

BNTX BioNTech
$104.00 /

+9.17 (+9.67%)

BA Boeing
$199.62 /

-6.01 (-2.92%)

On The Fly
Fly Intel: Wall Street's top stories at midday » 12:30
11/20/20
11/20
12:30
11/20/20
12:30
PFE

Pfizer

$36.64 /

+0.45 (+1.24%)

, BNTX

BioNTech

$101.50 /

+6.67 (+7.03%)

, FL

Foot Locker

$39.44 /

-1.915 (-4.63%)

, WDAY

Workday

$214.25 /

-16.55 (-7.17%)

, FEYE

FireEye

$15.19 /

+0.955 (+6.71%)

, BX

Blackstone

$58.77 /

+0.13 (+0.22%)

, MESO

Mesoblast

$13.93 /

+2.16 (+18.35%)

, NVS

Novartis

$87.29 /

+0.07 (+0.08%)

, WSM

Williams-Sonoma

$108.24 /

+7 (+6.91%)

, AVRO

Avrobio

$14.47 /

-2.48 (-14.63%)

, GSX

GSX Techedu

$59.25 /

-12.25 (-17.13%)

, POST

Post Holdings

$89.98 /

-6.62 (-6.85%)

The major averages are…

ShowHide Related Items >><<
WSM Williams-Sonoma
$108.24 /

+7 (+6.91%)

WDAY Workday
$214.25 /

-16.55 (-7.17%)

POST Post Holdings
$89.98 /

-6.62 (-6.85%)

PFE Pfizer
$36.64 /

+0.45 (+1.24%)

NVS Novartis
$87.29 /

+0.07 (+0.08%)

MESO Mesoblast
$13.93 /

+2.16 (+18.35%)

GSX GSX Techedu
$59.25 /

-12.25 (-17.13%)

FL Foot Locker
$39.44 /

-1.915 (-4.63%)

FEYE FireEye
$15.19 /

+0.955 (+6.71%)

BX Blackstone
$58.77 /

+0.13 (+0.22%)

BNTX BioNTech
$101.50 /

+6.67 (+7.03%)

AVRO Avrobio
$14.47 /

-2.48 (-14.63%)

PFE Pfizer
$36.64 /

+0.45 (+1.24%)

11/19/20
Fly Intel: Top five analyst initiations
11/19/20 Goldman Sachs
Pfizer reinstated with a Neutral at Goldman Sachs
11/17/20 Benchmark
Inovio on 'top-10 vaccine contenders list,' says Benchmark
11/17/20 Maxim
Co-Diagnostics price target lowered to $20 from $30 at Maxim
BNTX BioNTech
$101.50 /

+6.67 (+7.03%)

11/16/20 Piper Sandler
Piper boosts Moderna target to $166 after 'impressive' vaccine response
11/12/20 Canaccord
BioNTech price target raised to $115 from $112 at Canaccord
11/12/20 B. Riley Securities
Altimmune selloff on vaccine news overblown, says B. Riley Securities
FL Foot Locker
$39.44 /

-1.915 (-4.63%)

11/18/20 B. Riley Securities
Foot Locker price target raised to $36 from $30 at B. Riley Securities
11/18/20 Pivotal Research
Foot Locker price target raised to $46 from $39 at Pivotal Research
11/17/20 Wedbush
Foot Locker price target raised to $44 from $37 at Wedbush
11/16/20 Raymond James
Foot Locker price target raised to $50 from $35 at Raymond James
WDAY Workday
$214.25 /

-16.55 (-7.17%)

11/20/20 Loop Capital
Workday price target raised to $180 from $170 at Loop Capital
11/20/20 Canaccord
Workday weakness following earnings should be bought, says Canaccord
11/20/20 BMO Capital
Workday price target lowered to $260 from $265 at BMO Capital
11/20/20 Credit Suisse
Workday price target raised to $230 from $215 at Credit Suisse
FEYE FireEye
$15.19 /

+0.955 (+6.71%)

11/20/20 Barclays
FireEye downgraded to Underweight on long transformation at Barclays
11/20/20 Barclays
FireEye downgraded to Underweight from Equal Weight at Barclays
10/14/20 Baird
FireEye added as positive Fresh Pick ahead of earnings at Baird
07/29/20 JPMorgan
FireEye price target raised to $18 from $15 at JPMorgan
BX Blackstone
$58.77 /

+0.13 (+0.22%)

10/29/20 Oppenheimer
Blackstone upgraded to Outperform at Oppenheimer
10/29/20 Oppenheimer
Blackstone upgraded to Outperform from Perform at Oppenheimer
06/25/20
Fly Intel: Top five analyst initiations
06/25/20 UBS
Blackstone initiated with a Buy at UBS
MESO Mesoblast
$13.93 /

+2.16 (+18.35%)

10/22/20
Fly Intel: Top five analyst initiations
10/22/20 RBC Capital
Mesoblast initiated with a Sector Perform at RBC Capital
10/05/20 Maxim
Mesoblast price target lowered to $18 from $22 at Maxim
10/02/20 H.C. Wainwright
H.C. Wainwright cuts Mesoblast target after unexpected complete response letter
NVS Novartis
$87.29 /

+0.07 (+0.08%)

11/10/20 JPMorgan
Novartis price target raised to CHF 85 from CHF 82 at JPMorgan
10/26/20 JMP Securities
Kura Oncology price target raised to $33 from $22 at JMP Securities
09/29/20 Berenberg
Novartis initiated with a Buy at Berenberg
09/24/20 Barclays
Regenxbio price target lowered to $79 from $88 at Barclays
WSM Williams-Sonoma
$108.24 /

+7 (+6.91%)

11/20/20 RBC Capital
Williams-Sonoma price target raised to $117 from $101 at RBC Capital
11/20/20 Loop Capital
Williams-Sonoma price target raised to $110 from $100 at Loop Capital
11/20/20 Wedbush
Williams-Sonoma price target raised to $130 from $115 at Wedbush
11/20/20 Barclays
Williams-Sonoma price target raised to $144 from $112 at Barclays
AVRO Avrobio
$14.47 /

-2.48 (-14.63%)

11/18/20 Mizuho
Avrobio price target raised to $43 from $35 at Mizuho
11/11/20 Berenberg
Biotechnology companies initiated at Berenberg
11/11/20 Berenberg
Avrobio initiated with a Buy at Berenberg
03/31/20 H.C. Wainwright
Avrobio downgraded to Neutral from Buy at H.C. Wainwright
GSX GSX Techedu
$59.25 /

-12.25 (-17.13%)

10/26/20 Barclays
GSX Techedu price target lowered to $66 from $77 at Barclays
10/22/20
Fly Intel: Top five analyst downgrades
10/22/20 Nomura
Nomura downgrades GSX Techedu to Reduce, cuts target to 'Street-low' $38
10/22/20 Nomura
GSX Techedu downgraded to Reduce from Neutral at Nomura
POST Post Holdings
$89.98 /

-6.62 (-6.85%)

06/22/20 Goldman Sachs
Post Holdings upgraded to Buy from Neutral at Goldman Sachs
05/04/20 Wells Fargo
Post Holdings price target lowered to $110 from $120 at Wells Fargo
04/09/20
Fly Intel: Top five analyst initiations
04/09/20 Citi
Post Holdings assumed with a Buy at Citi
WSM Williams-Sonoma
$108.24 /

+7 (+6.91%)

WDAY Workday
$214.25 /

-16.55 (-7.17%)

POST Post Holdings
$89.98 /

-6.62 (-6.85%)

PFE Pfizer
$36.64 /

+0.45 (+1.24%)

NVS Novartis
$87.29 /

+0.07 (+0.08%)

MESO Mesoblast
$13.93 /

+2.16 (+18.35%)

GSX GSX Techedu
$59.25 /

-12.25 (-17.13%)

FL Foot Locker
$39.44 /

-1.915 (-4.63%)

FEYE FireEye
$15.19 /

+0.955 (+6.71%)

BX Blackstone
$58.77 /

+0.13 (+0.22%)

BNTX BioNTech
$101.50 /

+6.67 (+7.03%)

AVRO Avrobio
$14.47 /

-2.48 (-14.63%)

  • 20
    Nov
  • 23
    Jul
  • 13
    Feb
  • 06
    Feb
  • 21
    Nov
WSM Williams-Sonoma
$108.24 /

+7 (+6.91%)

POST Post Holdings
$89.98 /

-6.62 (-6.85%)

PFE Pfizer
$36.64 /

+0.45 (+1.24%)

NVS Novartis
$87.29 /

+0.07 (+0.08%)

GSX GSX Techedu
$59.25 /

-12.25 (-17.13%)

FEYE FireEye
$15.19 /

+0.955 (+6.71%)

BX Blackstone
$58.77 /

+0.13 (+0.22%)

BNTX BioNTech
$101.50 /

+6.67 (+7.03%)

WSM Williams-Sonoma
$108.24 /

+7 (+6.91%)

WDAY Workday
$214.25 /

-16.55 (-7.17%)

PFE Pfizer
$36.64 /

+0.45 (+1.24%)

NVS Novartis
$87.29 /

+0.07 (+0.08%)

MESO Mesoblast
$13.93 /

+2.16 (+18.35%)

GSX GSX Techedu
$59.25 /

-12.25 (-17.13%)

FL Foot Locker
$39.44 /

-1.915 (-4.63%)

FEYE FireEye
$15.19 /

+0.955 (+6.71%)

BX Blackstone
$58.77 /

+0.13 (+0.22%)

AVRO Avrobio
$14.47 /

-2.48 (-14.63%)

WSM Williams-Sonoma
$108.24 /

+7 (+6.91%)

WDAY Workday
$214.25 /

-16.55 (-7.17%)

PFE Pfizer
$36.64 /

+0.45 (+1.24%)

MESO Mesoblast
$13.93 /

+2.16 (+18.35%)

GSX GSX Techedu
$59.25 /

-12.25 (-17.13%)

FL Foot Locker
$39.44 /

-1.915 (-4.63%)

FEYE FireEye
$15.19 /

+0.955 (+6.71%)

BX Blackstone
$58.77 /

+0.13 (+0.22%)

BNTX BioNTech
$101.50 /

+6.67 (+7.03%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.